🇺🇸 FDA
Patent

US 9603796

Controlled release antimicrobial compositions and methods for the treatment of otic disorders

granted A61KA61K31/43A61K31/496

Quick answer

US patent 9603796 (Controlled release antimicrobial compositions and methods for the treatment of otic disorders) held by The Regents of the University of California expires Mon Mar 23 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Mar 28 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 23 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61K, A61K31/43, A61K31/496, A61K31/522, A61K31/573